FPF
MDCO

FNY Partners Fund’s Medicines Co MDCO Stock Holding History

FNY Partners Fund’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed -$3K – 765
2017
Q2 		$3K Sell
100
-20
-17% -$891 ﹤0.01% 465
2017
Q1 		$3K Buy
120
+100
+500% +$4.56K ﹤0.01% 1269
2016
Q4 		$1 Buy
+20
New +$709 ﹤0.01% 576

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FNY Partners Fund's MDCO Position: Q3 2017 in Review

FNY Partners Fund sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 6,006 shares — an estimated $228K sold.

FNY Partners Fund first reported a position in MDCO in Q1 2017 and held it in 2 quarters. The position peaked at $228K in Q2 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

  • FNY Partners Fund reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
  • FNY Partners Fund sold 6,006 Medicines Co shares in Q3 2017, an estimated $228K.
  • FNY Partners Fund first reported a position in Medicines Co in Q1 2017 and held it in 2 quarters.
  • FNY Partners Fund's Medicines Co position peaked at $228K in Q2 2017.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.